GP
The startup develops an affordable, environmentally friendly insulin pen designed to enhance diabetes management by improving patient adherence and control. This solution aims to provide equitable access to quality diabetes care, ultimately reducing healthcare utilization costs for providers.
Updated 18 months ago
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops an affordable, environmentally friendly insulin pen designed to enhance diabetes management by improving patient adherence and control. This solution aims to provide equitable access to quality diabetes care, ultimately reducing healthcare utilization costs for providers.